A pill that works less every year. A clinic that charges $6,000 for the real fix. A doctor who hands you a prescription instead of a protocol.
If you live with erectile dysfunction past 40, you have heard the same conversation:
"Just take one before. It works for most guys."
That sentence is medical advice from 1998. The research has moved a long way since then. The clinical conversation has not caught up.
In May 2024, a study in the Journal of Sexual Medicine published a protocol that has the andrology community sitting up. The paper did not test pills. It tested the two FDA-cleared therapies that, used together at home, rebuild the underlying tissue pills only mask.
This article is the result of six months of reading that research, talking to users, and watching what is quietly happening inside private men's-health forums. The device built around the protocol is here.
The hardest part of writing this was not the science. It was watching readers email after the first draft and say the same thing.
Nobody had ever told them ED was vascular damage. They had been to two, three, sometimes five urologists. They had been handed Cialis. They had been told to "lose ten pounds and try again." Not one doctor had said the words acoustic shockwave out loud, even though it has been the gold-standard clinic protocol for ED recovery since 2017.
This is the article those readers wish they had been handed at their first appointment.
Five things almost nobody told you about erectile dysfunction.
- The two FDA-cleared therapies that rebuild vascular and nerve tissue at the source. Neither is a pill.
- Why Viagra works less every year — and why that is not your willpower.
- The 2024 Journal of Sexual Medicine paper that put the clinic protocol within reach of a home device.
- The 30-day refund window that quietly does more work than any other line in the offer.
- The $3,800 a year the pill industry needs you to keep spending so nothing actually changes.
Two FDA-cleared therapies, used together at home, rebuild the underlying tissue pills only mask.
You probably have not heard them named together.
Acoustic shockwave and pulsed electromagnetic field (PEMF). Two separate clinical modalities, both FDA-cleared, both validated in peer-reviewed urology research over the last decade.
Used in clinic, separately, they cost between $3,000 and $8,000 per six-week course. Used together, in the same session, in a home-format device, they are the protocol the 2024 paper describes.
Acoustic shockwave triggers angiogenesis — the growth of new blood vessels in vascular tissue that has been quietly declining since your late thirties. The pulse is gentle, almost a tapping, but the biological response is well-documented in the urology literature.
PEMF reactivates the cavernous nerve pathway — the network of nerves that carries arousal signals from the brain into erectile tissue. In men past 45, those signals weaken slowly, year by year, in a way that no pill addresses.
Under normal conditions, both systems work together automatically. Blood arrives. Nerves fire. The result is automatic. For millions of men past 45, both systems have quietly stopped doing their job.
- Take Viagra before
- Schedule the moment
- Hope the timing lands
- Refill the prescription monthly
- Add testosterone if it stops working
- Rebuild blood vessels
- Reactivate dormant nerve pathways
- Use the same dual therapy as the clinic
- 15 minutes, three times a week, at home
- The repair holds when the device is off
When the vascular and nerve systems are healthy, the erection happens on its own, on its own schedule, without a pill in the bloodstream. When the systems have declined, even a higher pill dose only papers over the gap for a few hours. Two men with identical pill prescriptions have radically different real lives. The difference is whether the underlying tissue is still doing its job.
The pill is the override. The vascular and nerve system is the engine. Almost every standard ED treatment leaves the engine untouched.
Urology training centers on diagnosis, pharmacology, and surgical intervention. Acoustic shockwave and PEMF are physical-therapy modalities — they fall into a gap between urology and physical medicine. The patient sitting in that gap is the one paying for it, in pills, every month, for the rest of his life.
Picture a tax that gets larger every year — and never actually solves the problem. That is roughly what Viagra is.
Viagra and Cialis work by forcing blood into vascular tissue that is already damaged.
When the tissue is healthy, the pill is unnecessary. When the tissue is mildly damaged, the pill works well. When the tissue has been quietly degrading for ten or fifteen years, the pill stops being enough — even at the maximum dose your doctor will prescribe.
This is not a side effect. It is the design. The pill never claimed to repair the tissue. It only claimed to override it for a few hours.
Most men past 50 are not failing the pill. The pill is doing exactly what it was built to do. The problem is that the tissue underneath keeps declining while the pill keeps the surface looking fine — and after enough years, the surface stops looking fine too.
Why every standard treatment has missed this.
Daily pills (low-dose Cialis, generic tadalafil) keep the override running 24 hours. They do not address the underlying decline. They are a permanent tax on the same broken engine.
Testosterone replacement raises baseline drive. It does not rebuild vascular tissue. For most men, drive was not the problem.
Clinic shockwave therapy ($3,000–$8,000) is the right modality, in the wrong package. The same protocol, delivered in someone else's office, on someone else's schedule, with a clipboard with your name on it, ten minutes from your house.
Penile injections and implants are real medical interventions for severe cases. For most men reading this, they are three steps further than necessary.
Each of these works around the underlying decline. None of them rebuilds the tissue.
You cannot rebuild damaged vascular tissue by swallowing a pill an hour before. You cannot rebuild it by adding testosterone. You rebuild it by stimulating the tissue itself — the same way clinics have been doing it since 2017.
My urologist had me on Cialis for six years. He never once said the words acoustic shockwave. Reading about the mechanism was the first thing that made the decline make sense.
A 2024 Journal of Sexual Medicine paper handed the field the dosing window the home market had been waiting for.
For a decade, urology had been running shockwave trials in clinics with promising results. The protocols were a mess.
Some studies used a pulse intensity too low to trigger angiogenesis. Some used a session length too long to be tolerable. Some had patients return weekly for six weeks; others biweekly for twelve. The field could not converge on a clean home-usable protocol.
The May 2024 Journal of Sexual Medicine paper changed that. It documented a dual-modality protocol — acoustic shockwave combined with low-frequency PEMF — over a 12-week home-applicable window:
- One applicator, dual-modality (acoustic + PEMF)
- Low-intensity pulse, well within home-safety thresholds
- 15 minutes per session, three times per week
- 12 weeks of consistent use, with results measured at week 8
What the paper measured at 12 weeks was not just self-reported function. It was Doppler-measured penile blood flow and IIEF-5 scores.
Blood flow improved. Erection firmness scores rose. The cohort that had relied on PDE-5 inhibitors before the study tapered off them naturally over the protocol window. The repair held at 6-month follow-up.
Within six months of publication, the andrology community recognized something the original authors had not been chasing — that the protocol the paper had standardized was the cleanest replication yet of the clinic shockwave outcomes, delivered in a home-friendly format.
The JSM paper handed the field a clean, replicable, at-home dosing window.
Introducing KORE Pulse. The first home device built to the JSM 2024 protocol exactly.
It looks like a small matte-black silicone applicator with a KORE Blue LED ring indicator.
Inside, it is pre-programmed with the exact dosing the paper used. Same pulse profile. Same dual-modality combination. Same 15 minutes. Same 12-week window. FDA-cleared for at-home use. Made in the United States.
It is not a generic massager. It is not a TENS unit. It is not a vibrating accessory. It is a precision-dosed at-home device built to deliver the published clinical parameters to the only tissue where they matter.
More than two dozen "men's wellness" devices are now on the market. KORE Pulse is the only one we have found built to the exact dosing in the published clinical paper.
I priced clinic shockwave at $6,200 in Chicago. My wife told me to do it. I bought KORE instead. Same modality, twelve weeks in, the rigidity is genuine — not chemical.
The 30-day refund is the part of the offer that is doing the most work.
Most ED supplements run on 14-day refund windows.
Open the box. Try the pill four times. Decide.
The problem with that math is biological. Vascular tissue does not respond in two weeks. Angiogenesis — the growth of new blood vessels — takes three to four weeks to begin measurable change, and eight weeks to deliver lived results. Nerve pathway reactivation runs on a similar curve.
A 14-day refund window is calibrated to expire before you can tell whether the protocol worked. That is not an accident. That is how the product's math is built. The customer keeps the product because the window closed. Not because anything changed.
A 30-day full refund is a confession from the company that they expect a month to be enough for you to feel the first real signal. A 14-day refund is a confession that they do not.
KORE offers 30 days. A full month of consistent use, three sessions a week. Full refund. No restocking fee. No follow-up call asking why.
That is the same early window the JSM paper used to measure the first measurable change in blood flow markers. Not a marketing number. The clinical number.
A company offering 30 days at full refund has done the math and decided most users will keep the device. Subscription pill services almost never offer this. The math does not work for them.
I only tried it because of the 30 days. I had three years of buying ED products with a 14-day window. By the time I knew if they worked, the window was closed.
The $3,800 a year the men's-health industry needs you to keep spending so nothing actually changes.
Most men with chronic ED have never sat down and added up the line items.
Cialis subscriptions. Telehealth visit fees. Generic tadalafil from the lookalike app. Supplements with arginine and yohimbine. Couples therapy copays. Each line item is small enough to ignore on its own. Together, every year, it is the cost of a vacation that does not get taken.
The math behind that industry only works if you stay roughly the same. A real one-time fix would collapse the model. Which is why the model does not produce one.
Most KORE users do not drop the entire stack on day one. They keep the therapist, sometimes for a while. They keep a supplement they trust. But the daily Cialis subscription and the quarterly telehealth visit they were paying for out of habit quietly stop around week 8 or 9. The math then changes for years.
A one-time tool with a real, lasting effect breaks the economic model of the chronic-ED industry. That should be a feature, not a problem.
I cancelled my Hims subscription and my TRT clinic membership in the same month. Not because anyone told me to. Because I noticed I had stopped opening the pill bottle.
Guarantee
Shipping
Checkout
Returns
This is your shot at the morning before.
A small device. Fifteen minutes, three times a week. The same dual-therapy the JSM paper documented. Thirty days at home to find out if your vascular system is the part of this you have not yet tried.
Start your 90 days →Six months of reading the research and talking to KORE users produced one consistent observation.
Almost none of them said the change was sudden.
What they said was the first morning they woke firm without thinking about it, the first time they reached for their partner without doing the mental rehearsal first, the first week they realised the pill bottle on the nightstand had been sitting unopened. That moment usually landed somewhere between week 5 and week 9. Thirty days is enough time for the first real signal. Twelve weeks is enough time for the change to hold. That is the reason the 30-day refund matters more here than almost anywhere else in men's health.
The Andrology Review may earn an affiliate commission on sales generated through links in this article. Editorial opinions are our own.